Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • IDWeek Highlights |Dr. Yi-min Wang: Bundle Diagnosis for VAP Can Reduce Misdiagnosis and Antibiotic Overuse

    Precision treatment starts with accurate diagnosis. The clinical diagnosis of ventilator-associated pneumonia (VAP) is challenging, with a high misdiagnosis rate leading to excessive antibiotic use. At the recent 2023 IDWeek conference in the United States, a clinical trial was reported that utilized a bundled approach to VAP diagnosis and management. The results showed that it…

    2023.11.27
  • Dr. Chun-hui Li’s Commentary on a Randomized Controlled Trial of Oral Fosfomycin for Down-Step Therapy in ESBL-E Complicated Urinary Tract Infections

    Carbapenem-resistant Enterobacteriaceae (CRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) have been designated as “urgent priorities” in antibiotic research and development by the WHO. Besides accelerating the development of new drugs, emphasizing the “repurposing” of existing drugs under antimicrobial stewardship (AMS) can help alleviate the threat of resistant bacteria. At the 2023 IDWeek congress, There is a…

    2023.11.27
  • IDWeek Highlights |  Dr. Jun-yan Qu Comments on a Real-world study of CT vs. CZA in Treating MDR-PA Infections

      Editor’s note: Multi-drug resistant organisms (MDRO) are commonly found in bacteria such as Enterobacteriaceae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. In recent years, the emergence and spread of…

    2023.11.27
  • Prof. Min-Shan Chen: The Key to Liver Cancer Control Lies in the Integration of Medical Concepts and Multidisciplinary Collaboration

    Editor’s Note: The 2023 Chinese Congress on Holistic Integrative Oncology (CCHIO), organized by the China Anti-Cancer Association and hosted by Tianjin Medical University Cancer Hospital, will take place in Tianjin…

    2023.11.27
  • IDWeek Highlights | Dr. Yi Shi  Comments on a Single-Center Cohort Study of Colistin Therapy for CRAB Pneumonia

    Carbapenem-resistant Acinetobacter baumannii (CRAB) infection is considered one of the most challenging issues among carbapenem-resistant gram-negative bacteria (CRO) due to limited effective treatment options. Colistin, a polymyxin antibiotic used for “repurposing” in the treatment of CRAB, is one of the few choices available in China. A recent presentation at the 2023 IDWeek congress reported findings…

    2023.11.27
  • Message from Academician Fan Daiming for the 2023 Chinese Congress of Holistic Integrative Oncology

    Editor’s Note: Gathering Expertise in China, Uniting Wisdom Across the World. Organized by the China Anti-Cancer Association and hosted by Tianjin Medical University Cancer Institute & Hospital, Tianjin Anti-Cancer Association,…

    2023.11.27
  • Prof. Cai-Cun Zhou: Adding More Chinese Voices and Strength to International Lung Cancer Practice

    Editor’s Note: The “2023 Chinese Congress of Holistic Integrative Oncology (2023 CCHIO),” hosted by the China Anti-Cancer Association, and organized by Tianjin Medical University Cancer Institute & Hospital, Tianjin Anti-Cancer…

    2023.11.27
  • Alexander Mundinger:

    Cost-Effectiveness of Breast Cancer Screening Editor’s Note: The 2023 China Congress of Integrative Oncology (2023 CCHIO) will be held in Tianjin from November 16th to 19th, 2023. Dr. Alexander Mundinger,…

    2023.11.27
«previous next»
Recent Posts
  • Prof. Wang Liang: How to Precisely Choose Between Autologous and Allogeneic Transplantation for First-Line Consolidation in Peripheral T-Cell Lymphoma? | 2026 Cross-Strait Hematology Conference
  • Professor Huang He: Advances in Novel Cellular Immunotherapy and Clinical Translation丨2026 Cross-Strait Hematology Academic Conference
  • CACA GU丨Yiping Zhu: Advancing Standardized, Whole-Course Bladder Cancer Management—from First-Line Treatment Innovation to Multidisciplinary Collaboration
  • 2026 Pujiang Urological Oncology Academic Conference丨Yijun Shen: ADCs Are Driving Bladder-Preservation Strategies Toward Precision Combination Therapy—from Combination Treatment in High-Risk NMIBC and MIBC Pathway Reshaping to Molecular Biomarker Stratification
  • 2026 Pujiang Urological Oncology Academic Conference丨Professor Guohai Shi: From Combination Therapy to Whole-Course Management, Advancing Long-Term Benefit in Advanced Renal Cell Carcinoma
Recent Comments
    Archives
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top